857787-75-8

Basic information

• Product Name: ethyl 7-(phenoxy)heptanoate
• Synonyms: ethyl 7-(phenoxy)heptanoate
• CAS NO: 857787-75-8
• Molecular Weight: 250.338
• Mol File: 857787-75-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 7-(phenoxy)heptanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 7-(phenoxy)heptanoate(857787-75-8)
• EPA Substance Registry System: ethyl 7-(phenoxy)heptanoate(857787-75-8)

Safety Data

• Hazardous Substances Data: 857787-75-8(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 7170-42-5 7-phenoxy-heptanoic acid 
• 51795-97-2 6-bromohexyloxybenzene 
• 151-50-8 potassium cyanide 
• 29823-18-5 ethyl 7-bromoheptanoate 
• 108-95-2 phenol 
• 629-03-8 1 ,6-dibromohexane 
• 7170-40-3 5-phenoxyvaleric acid 
• 201230-82-2 carbon monoxide 
• 74972-56-8 (hex-5-en-1-yloxy)benzene 
• 139-02-6 sodium phenoxide 
• 69687-95-2 ethyl 5-(phenoxy)pentanoate 
• 16654-52-7 5-phenoxy-1-pentanol 
• 82258-47-7 (5-phenoxy-pentyl)-malonic acid diethyl ester 

Downstream Products

• 1004305-57-0 7-phenoxyheptanal 
• 71933-98-7 dimethyl-(7-phenoxy-heptyl)-amine 
• 51795-98-3 1-bromo-7-phenoxyheptane 
• 16654-56-1 7-phenoxyheptan-1-ol 

Relevant articles and documents

Regioselective Alkoxycarbonylation of Allyl Phenyl Ethers Catalyzed by Pd/dppb under Syngas Conditions

A simple and regioselective synthesis of phenoxy esters and phenylthio esters is reported. The products are obtained by selective alkoxycarbonylation catalyzed by Pd2(dba)3, 1,4-bis(diphenylphisphino)butane (dppb), and syngas (CO/H2) in chloroform/alcohol. This methodology affords bifunctional products in good yield with excellent n-selectivity and without the need to use additives.

MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY

Disclosed are compounds and compositions that inhibit the action of monoacylglycerol lipase (MGL) and fatty acid amide hydrolase (FAAH), methods of inhibiting MGL and FAAH, methods of modulating cannabinoid receptors, and methods of treating various disorders related to the modulation of cannabinoid receptors.